By Francesco Guarascio and Bart Biesemans BRUSSELS (Reuters) - EU authorities say there is no conclusive evidence of a cancer...
Read moreBy Pushkala Aripaka (Reuters) -Britain on Thursday became the first country in the world to approve a potentially game-changing COVID-19...
Read moreBy Carl O'Donnell and Michael Erman NEW YORK (Reuters) - The COVID-19 vaccine for children aged 5 to 11 from...
Read moreBy Carl O'Donnell and Dania Nadeem (Reuters) -Novavax Inc expects regulators in India, the Philippines and elsewhere to make a...
Read moreBy Stephanie Nebehay GENEVA (Reuters) -The World Health Organization (WHO) and other aid groups on Thursday appealed to leaders of...
Read moreBy Carl O'Donnell (Reuters) - Moderna Inc's COVID-19 vaccine could start to be used in children and teens in the...
Read moreBy Manas Mishra and Michael Erman (Reuters) - An expert panel on Tuesday voted overwhelmingly to recommend the U.S. Food...
Read moreOTTAWA (Reuters) - Members of Toronto's police, the largest municipal force in Canada, will be placed on unpaid leave if...
Read moreBy David Shepardson WASHINGTON (Reuters) -The United States will accept the use by international visitors of COVID-19 vaccines authorized by...
Read moreBy Panarat Thepgumpanat BANGKOK (Reuters) -Thailand's government is in talks with Merck & Co to buy 200,000 courses of its...
Read moreBy Michael Erman, Gwladys Fouche and Alistair Smout (Reuters) - School for children in many nations has been underway for...
Read moreBy Michael Erman (Reuters) - The U.S. CDC on Friday backed a booster shot of the Pfizer/BioNTech COVID-19 vaccine for...
Read more(Reuters) - Europe's drugs regulator said on Friday it could not confirm if women and young adults were at a...
Read moreBEIJING (Reuters) -China's People's Daily newspaper said it was "imperative and urgent" to regulate advertisements bombarding people with recommendations for...
Read more